Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2012
10/10/2012CN102718847A Small molecular superantigen modified protein, its encoding gene, preparation process and application thereof
10/10/2012CN102718846A Activity-increased SEC 2 mutant protein, coding gene, preparation and application
10/10/2012CN102718845A Application of gene in nurturing anti-paraquat transgenic plant
10/10/2012CN102718844A Antimicrobial peptide AMitP with acid activation property and synthesis and application thereof in preparation of anti-tumor medicaments
10/10/2012CN102718670A Ractopamine hapten, artificial antigen and preparation methods for Ractopamine hapten and artificial antigen
10/10/2012CN102718651A Diethylstilbestrol hapten, artificial antigen and preparation methods for diethylstilbestrol hapten and artificial antigen
10/10/2012CN102716466A Application of major histocompatibility complex II (MHC II) molecules on preparation of drugs for preventing and curing animal immunodepression
10/10/2012CN102268445B Separation and in-vitro mutation of necrosis-inducing protein gene Pcnpp1 of Phytophthora capsici, and preparation method for silent mutant of gene
10/10/2012CN102206667B Recombinant plasmid pET32a-hIL-23R-CHR and construction and expression thereof
10/10/2012CN102093982B H9N2 subtype avian influenza virus strain and application thereof
10/10/2012CN101914546B Amphioxus saccharide pattern-recognition molecule Bjfcn1 gene and application thereof
10/10/2012CN101906156B Structures and application of bifunctional protein and derivatives of bifunctional protein
10/10/2012CN101899469B Shuttle plasmid and method for efficiently expressing cecropin and lysozyme genes
10/10/2012CN101899105B Recombinant erythropoietin and preparation method thereof
10/10/2012CN101885768B Mercury ion antigens and preparation method and application thereof
10/10/2012CN101880675B High-level expression of tetanus toxin receptor binding domain Hc in Escherichia coli and application
10/10/2012CN101880322B Co-production process for immune globulin and high-density lipoprotein in poultry egg yolk
10/10/2012CN101845084B Recombination polypeptide serving as group A streptococcic tetravalent vaccine protective antigen
10/10/2012CN101817878B Monomer quick-acting insulin as well as preparing method and application thereof
10/10/2012CN101633690B Hydrogen production associated protein, coding genes thereof and application thereof
10/10/2012CN101613395B Improved gene construction method and property testing of fast-acting insulin precursor
10/10/2012CN101610786B Prevention and treatment of sub-clinical pcvd
10/10/2012CN101608186B Method for preparing transgenic goat with high expression of human lactoferrin by somatic cell transfection
10/10/2012CN101580544B Colloidal gold labelled monoclonal antibody immunity detection Plate for detecting cannabis and tetrahydrocannabinol
10/10/2012CN101492490B Improved Cry3 method, improved Cry3, plasmid and uses thereof
10/10/2012CN101444624B Medicine for cancer therapy
10/10/2012CN101405394B D-amino acid selection for soybean
10/10/2012CN101389650B Compositions comprising an acylated insulin and zinc and method of making the said compositions
10/10/2012CN101370825B Novel FSH glycosylation variant D3N
10/10/2012CN101351550B Chimaeric fusion protein with superior chaperone and folding activities
10/10/2012CN101322033B Method for detecting autoimmune antibodies against TSH receptors and novel TSH-receptor chimaeras
10/10/2012CN101287988B Methods and compositions for diagnosis and treatment of influenza
10/10/2012CN101287484B Binding agents which inhibit myostatin
10/10/2012CN101198624B IL-31 monoclonal antibodies and methods of use
10/10/2012CN101193912B Acute leukemia and lymphoblastic lymphoma-specific cd43 epitope and use thereof
10/10/2012CN101151276B Method of producing protein by using hamster IGF-1
10/10/2012CN101052645B Cell cycle reporting cell line
10/10/2012CN101052414B Immunogenic HBc chimer particles having enhanced stability
10/09/2012US8283524 Bacillus thuringiensis gene with lepidopteran activity
10/09/2012US8283521 Transcription factor gene induced by water deficit conditions and abscisic acid from Helianthus annuus, promoter and transgenic plants
10/09/2012US8283518 Administration of transposon-based vectors to reproductive organs
10/09/2012US8283458 VMP-like sequences of pathogenic Borrelia species and strains
10/09/2012US8283452 Assay for the separation and quantification of hemagglutinin antigens
10/09/2012US8283449 Interleukin-2/soluble TGA-beta type II receptor B conjugates and methods and uses thereof
10/09/2012US8283448 Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
10/09/2012US8283447 Immunosuppressive polypeptides and nucleic acids
10/09/2012US8283446 T cell receptor mutants
10/09/2012US8283445 Extracellular-signal-regulated-kinase (ERK) heteropolyligand polypeptide
10/09/2012US8283444 Non-viral delivery of compounds to mitochondria
10/09/2012US8283441 Na+K+-ATPase-specific peptide inhibitors/activators of SRC and SRC family kinases
10/09/2012US8283439 Recombinant fragments and synthetic peptides of 17-kDa polypeptide useful in detecting Bartonella henselae
10/09/2012US8283334 Inhibitors of TGF-R signaling for treatment of CNS disorders
10/09/2012US8283324 Immunomodulatory and anti-tumour peptides
10/09/2012US8283322 Formulations for nonsurgical exogenous crosslink therapy
10/09/2012US8283321 Kallikrein-binding “Kunitz domain” proteins and analogues thereof
10/09/2012US8283320 Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostasis
10/09/2012US8283319 Therapeutic application of Kazal-type serine protease inhibitors
10/09/2012US8283318 Aquaretic and natriuretic polypeptides lacking vasodilatory activity
10/09/2012US8283313 Methods of increasing platelet and hematopoietic stem cell production
10/09/2012US8283307 Treatment of fibrotic disease
10/09/2012US8283150 Superactive cellulase formulation using cellobiohydrolase-1 from Penicillium funiculosum
10/09/2012US8283138 Method for the high level expression of active tumor necrosis receptor family member immunoglobulin fusion proteins
10/09/2012US8283137 Process for producing recombinant fibrinogen highly producing cell and highly producing cell
10/09/2012US8283126 Voltage sensor domains of voltage-dependent ion channel proteins and uses thereof
10/09/2012US8282963 Methods for extracting platelets and compositions obtained therefrom
10/09/2012US8282941 Immunizing compositions and methods of use
10/09/2012US8282940 Adjuvant viral particle
10/09/2012US8282935 Intensify immunology response; administering epitopes; polynucleotide sequences
10/09/2012US8282934 Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology
10/09/2012US8282933 genetic engineered proteins useful as immunogens in vaccines; prevention of periodontal disease
10/09/2012US8282931 Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
10/09/2012US8282915 Transgenic algae for delivering antigens to an animal
10/09/2012CA2711685C Modified nodavirus rna for gene delivery
10/09/2012CA2536923C Extracellular matrix composite materials, and manufacture and use thereof
10/09/2012CA2494197C Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
10/09/2012CA2466474C Compositions comprising spa-1, spa-2 and spa-3, polypeptides and related uses
10/09/2012CA2455830C Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans
10/09/2012CA2417415C Expression of biologically active polypeptides in duckweed
10/09/2012CA2414782C Intron associated with myotonic dystrophy type 2 and methods of use
10/09/2012CA2408847C Cng3b: a novel cyclic nucleotide-gated cation channel
10/09/2012CA2382035C Synthetic compounds having two epitopes in immunoassay
10/09/2012CA2358517C Method and composition for angiogenesis inhibition
10/09/2012CA2243845C Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity
10/09/2012CA2164698C Synthetic peptide inhibitors of hiv transmission
10/04/2012WO2012135659A2 Methods for enhancing the degradation or conversion of cellulosic material
10/04/2012WO2012135501A2 Axmi232, axmi233, and axmi249 toxin genes and methods for their use
10/04/2012WO2012135436A1 Axmi238 toxin gene and methods for its use
10/04/2012WO2012135177A2 Methods and compositions for cytomegalovirus il-10 protein
10/04/2012WO2012134975A1 Methods and compositions employing immunogenic fusion proteins
10/04/2012WO2012134921A2 Plant regulatory elements and uses thereof
10/04/2012WO2012134591A2 Plasmodium falciparum antigens
10/04/2012WO2012134262A2 A method for extracting protein from pectin rich plant material
10/04/2012WO2012134039A1 Protein having antigen activity against liver flukes
10/04/2012WO2012133825A1 Hot flash suppressant
10/04/2012WO2012133811A1 Regulator of anaplastic state and applications therefor
10/04/2012WO2012133610A1 Cell adhesion protein
10/04/2012WO2012133349A1 Protein for affinity-separation matrix
10/04/2012WO2012133342A1 Novel immunoglobulin-binding polypeptide
10/04/2012WO2012133127A1 Method for distinguishing between species in the genus staphylococcus
10/04/2012WO2012131680A2 Compositions and methods for treating inflammation
1 ... 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 ... 2916